Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices

References

• Crohn B, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am. J. Med. Sci.170, 220–227 (1925).
   Google Scholar
• Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment. Pharmacol. Ther.23(8), 1097–1104 (2006).
   PubMed Web of Science ®Google Scholar
• Clevers H. Colon cancer – understanding how NSAIDs work. N. Engl. J. Med.354(7), 761–763 (2006).
   PubMed Web of Science ®Google Scholar
• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut48(4), 526–535 (2001).
   PubMed Web of Science ®Google Scholar
• Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am. J. Gastroenterol.100(12), 2724–2729 (2005).
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med.23(18), 1228–1233 (1990).
   Google Scholar
• Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin. Gastroenterol. Hepatol.2(12), 1088–1095 (2004).
   PubMed Web of Science ®Google Scholar
• Jess T, Loftus EV, Velayos FS et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology130(4), 1039–1046 (2006).
   PubMed Web of Science ®Google Scholar
• Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin. Gastroenterol. Hepatol.4(3), 335–342 (2006).
   PubMed Web of Science ®Google Scholar
• Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J. Clin. Gastroenterol.36(5 Suppl.), S70–S74; discussion S94–S96 (2003).
   PubMedGoogle Scholar
• Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology126(6), 1634–1648 (2004).
   PubMed Web of Science ®Google Scholar
• Brentnall TA, Crispin DA, Rabinovitch PS et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology107(2), 369–378 (1994).
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol.287(1), G7–G17 (2004).
   PubMed Web of Science ®Google Scholar
• Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest. Endosc.56(1), 48–54 (2002).
   PubMed Web of Science ®Google Scholar
• Askling J, Dickman PW, Karlen P. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology120(6), 1356–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case–control study. Aliment. Pharmacol. Ther.14(2), 145–153 (2000).
   PubMed Web of Science ®Google Scholar
• Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: a case–control study. Gastroenterology107(1), 117–120 (1994).
   PubMed Web of Science ®Google Scholar
• Rutter M, Saunders B, Wilkinson K et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology126(2), 451–459 (2004).
   PubMed Web of Science ®Google Scholar
• Rubin DT, Huo D, Rothe JA et al. Increased inflammatory activity is an independent risk factor for dysplasia and colorectal cancer in ulcerative colitis: a case–control analysis with blinded prospective pathology review. Gastroenterology130(4), A2 (2006).
   Google Scholar
• Bansal R, Itzkowitz S, Harpaz N et al. Severity of inflammation predicts progression to colorectal neoplasia in ulcerative colitis. Am. J. Gastroenterol.100(9), S289 (2005).
   Google Scholar
• Gupta RB, Harpaz N, Itzkowitz S et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology133(4), 1099–1105 (2007).
   PubMed Web of Science ®Google Scholar
• Velayos FS, Loftus EV, Jess T et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case–control study. Gastroenterology130(7), 1941–1949 (2006).
   PubMed Web of Science ®Google Scholar
• Siegel CA, BE Sands. Risk factors for colorectal cancer in Crohn’s colitis: a case–control study. Inflamm. Bowel Dis.12(6), 491–496 (2006).
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut53(12), 1813–1816 (2004).
   PubMed Web of Science ®Google Scholar
• Heuschen UA, Hinz U, Allemeyer EH et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology120(4), 841–847 (2001).
   PubMed Web of Science ®Google Scholar
• Shelton AA, Lehman RE, Schrock TR, Welton ML. Retrospective review of colorectal cancer in ulcerative colitis at a tertiary center. Arch. Surg.131(8), 806–810; discussion 810–811 (1996).
   PubMedGoogle Scholar
• Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm. Bowel Dis.11(3), 314–321 (2005).
   PubMed Web of Science ®Google Scholar
• Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale – update based on new evidence. Gastroenterology.124(2), 544–560 (2003).
   PubMed Web of Science ®Google Scholar
• Broomé U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis. Colon Rectum.38(12), 1301–1305 (1995).
   PubMed Web of Science ®Google Scholar
• Bernstein CN. A balancing view: dysplasia surveillance in ulcerative colitis – sorting the pro from the con. Am. J. Gastroenterol.99(9), 1636–1637 (2004).
   PubMed Web of Science ®Google Scholar
• Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology105(2), 418–424 (1993).
   PubMed Web of Science ®Google Scholar
• Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology107(4), 934–944 (1994).
   PubMed Web of Science ®Google Scholar
• Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson P, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut42(5), 711–714 (1998).
   PubMed Web of Science ®Google Scholar
• Connell WR, Talbot IC, Harpaz N et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut35(10), 1419–1423 (1994).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet343(8889), 71–74 (1994).
   PubMed Web of Science ®Google Scholar
• Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest. Endosc.51(2), 123–128 (2000).
   PubMed Web of Science ®Google Scholar
• Rubin CE, Haggitt RC, Burmer GC et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology103(5), 1611–1620 (1992).
   PubMed Web of Science ®Google Scholar
• Thomas T, Nair P, Dronfield MW, Mayberry JF. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists’ perspective and current practice in the United Kingdom. Eur. J. Gastroenterol. Hepatol.17(12), 1317–1324 (2005).
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology130(4), 1030–1038 (2006).
   PubMed Web of Science ®Google Scholar
• Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut51(Suppl. 5), V10–V12 (2002).
   PubMed Web of Science ®Google Scholar
• Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology103(2), 431–438 (1992).
   PubMed Web of Science ®Google Scholar
• Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J. Pathol.194(2), 152–157 (2001).
   PubMed Web of Science ®Google Scholar
• Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology125(5), 1311–1319 (2003).
   PubMed Web of Science ®Google Scholar
• Ullman TA, Loftus EV Jr, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. The fate of low grade dysplasia in ulcerative colitis. Am. J. Gastroenterol.97(4), 922–927 (2002).
   PubMed Web of Science ®Google Scholar
• Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Twenty years’ colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand. J. Gastroenterol.31(12), 1195–1204 (1996).
   PubMed Web of Science ®Google Scholar
• Befrits R, Ljung T, Jaramillo E, Rubio C. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis. Colon Rectum45(5), 615–620 (2002).
   PubMed Web of Science ®Google Scholar
• Lim CH, Dixon MF, Vail A, Forman D, Lynch DAF, Axon ATR. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut52(8), 1127–1132 (2003).
   PubMed Web of Science ®Google Scholar
• Rubio CA. Serrated neoplasias and de novo carcinomas in ulcerative colitis: a histological study in colectomy specimens. J. Gastroenterol. Hepatol.22(7), 1024–1031 (2007).
   PubMed Web of Science ®Google Scholar
• Ullman TA. Colonoscopic surveillance in inflammatory bowel disease. Curr. Opin. Gastroenterol.21(5), 585–588 (2005).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Weinstein WM, Levine DS, Shanahan F. Physicians’ perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am. J. Gastroenterol.90(12), 2106–2114 (1995).
   PubMed Web of Science ®Google Scholar
• Kiesslich R, Neurath MF. Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight. Gut53(2), 165–167 (2004).
   PubMed Web of Science ®Google Scholar
• Hurlstone DP, McAlindon ME, Sanders DS, Keogh R, Lobo AJ, Cross SS. Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology126(1), 376–378 (2004).
   PubMed Web of Science ®Google Scholar
• Kiesslich R, Fritsch J, Holtmann M et al., Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology124(4), 880–888 (2003).
   PubMed Web of Science ®Google Scholar
• Hurlstone DP, Sanders DS, Lobo AJ, Mcalindon ME, Cross SS. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy37(12), 1186–1192 (2005).
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut53(2), 256–260 (2004).
   PubMed Web of Science ®Google Scholar
• Allgayer H. Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment. Pharmacol. Ther.18(Suppl. 2), 10–14 (2003).
   PubMed Web of Science ®Google Scholar
• Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am. J. Gastroenterol.100(6), 1345–1353 (2005).
   PubMed Web of Science ®Google Scholar
• Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am. J. Gastroenterol.91(1), 44–48 (1996).
   PubMed Web of Science ®Google Scholar
• Tung BY, Emond MJ, Haggitt RC. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann. Intern. Med.134(2), 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology124(4), 889–893 (2003).
   PubMed Web of Science ®Google Scholar
• Lashner B, Provencher K, Seidner D, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology112(1), 29–32 (1997).
   PubMed Web of Science ®Google Scholar
• Kiesslich R, Goetz M, Angus EM et al. Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology133(6), 1769–1778 (2007).
   PubMed Web of Science ®Google Scholar
• Katagiri A, Fu KI, Sano Y et al. Narrow band imaging with magnifying colonoscopy as diagnostic tool for predicting histology of early colorectal neoplasia. Aliment. Pharmacol. Ther.27(12), 1269–1274 (2008).
   PubMed Web of Science ®Google Scholar